CBD and Methotrexate: What Does the Science Say? - Mustaf Medical

The Intersection of CBD and Methotrexate

Recent clinical data and a growing interest in wellness have brought attention to the concurrent use of various supplements and prescription medications. One area of increasing curiosity is the combination of cannabidiol (CBD), a compound derived from the cannabis plant, and methotrexate, a medication used for a range of conditions. Individuals managing chronic inflammation or seeking to support their overall wellness are often the ones exploring this combination. The scientific community is actively investigating how these substances interact, particularly since both are processed by the liver. It's important to approach this topic with an understanding that evidence is still emerging, and effects can vary significantly from person to person.

Background on CBD and Methotrexate

Cannabidiol (CBD) is one of over 100 chemical compounds known as cannabinoids found in the cannabis plant. Unlike tetrahydrocannabinol (THC), CBD is not psychoactive, meaning it doesn't produce the "high" associated with marijuana. CBD is available in various forms, including oils, capsules, and edibles like gummies. Its interaction with the body's endocannabinoid system-a complex cell-signaling system involved in regulating processes like sleep, appetite, pain, and immune system response-is a primary focus of research. The Food and Drug Administration (FDA) has approved one CBD-based drug, Epidiolex, for the treatment of certain rare seizure disorders. Research into other potential benefits for anxiety, pain, and sleep disturbances is ongoing, though findings are still developing.

Methotrexate is a well-established medication classified as a disease-modifying antirheumatic drug (DMARD) and an antimetabolite. It is prescribed for various autoimmune diseases, such as rheumatoid arthritis and psoriasis, and is also used in higher doses as a chemotherapy agent for certain cancers. It functions by interfering with the growth of certain cells and by suppressing the immune system to reduce inflammation. Due to its mechanism of action, patients taking methotrexate require regular monitoring by a healthcare professional to manage potential side effects, which can include liver issues, mouth sores, and bone marrow suppression.

Science and Mechanism of Interaction

The primary concern regarding the interaction between CBD and methotrexate lies in their shared metabolic pathways, specifically within the liver. Both substances are metabolized by the cytochrome P450 (CYP450) family of enzymes. CBD has been shown to be a potent inhibitor of certain CYP450 enzymes, particularly CYP3A4 and CYP2C19.

This inhibition is significant because these enzymes are responsible for breaking down a vast number of drugs, including methotrexate. When an enzyme is inhibited, it can slow down the metabolism of other drugs that rely on the same pathway. This can lead to a higher concentration of the drug remaining in the bloodstream for a longer period. In the case of methotrexate, an increase in its concentration could amplify its therapeutic effects but also significantly elevate the risk of toxicity and serious side effects.

Conversely, some research suggests CBD can also induce, or speed up, the activity of other enzymes. If CBD were to induce an enzyme responsible for methotrexate's breakdown, it could theoretically lower the medication's effectiveness.

Furthermore, both CBD and methotrexate are associated with potential liver effects. Methotrexate can cause elevations in liver enzymes, and in rare cases, more serious liver damage. High doses of CBD have also been linked to liver enzyme elevations in some studies. The concurrent use of two substances that can both impact the liver raises theoretical concerns about an increased risk of hepatotoxicity (liver injury). Therefore, close monitoring of liver function through blood tests is crucial for anyone taking methotrexate, and this becomes even more pertinent if they are also using CBD.

Animal studies have explored CBD's potential to mitigate some of methotrexate's side effects. For instance, research in rats suggested that CBD's anti-inflammatory and antioxidant properties might offer protective effects against methotrexate-induced lung damage, neuroinflammation, and liver injury. However, these are preclinical findings, and it is crucial to understand that results from animal studies do not always translate to humans. There is a lack of robust clinical trials in humans to confirm these protective effects or to establish safe co-administration guidelines. One observational study in rheumatology practice noted that CBD oil could increase levels of methotrexate in the blood, underscoring the need for careful monitoring.

Comparative Context: Forms of CBD Intake

Understanding how CBD is absorbed and metabolized is key to comprehending its potential interactions. Different forms of CBD products have varying bioavailability and metabolic pathways.

Form/Source Absorption/Metabolic Impact Studied Intake Ranges Limitations Populations Studied
Oral (e.g., Gummies, Capsules) Undergoes "first-pass metabolism" in the liver; metabolized by CYP450 enzymes. Bioavailability is relatively low (11-45%). Doses up to 1500 mg/day have been studied for chronic use. Onset of effects is slower. The amount absorbed can be inconsistent. Healthy volunteers and patients in various clinical trials (e.g., epilepsy, anxiety).
Sublingual (e.g., Tinctures, Sprays) Absorbed directly into the bloodstream through mucous membranes, largely bypassing the liver's first-pass effect. Half-life can range from 1.4 to 10.9 hours. Effects may not last as long as oral ingestion. Dosage can be difficult to measure precisely. Healthy volunteers.
Topical (e.g., Creams, Lotions) Applied to the skin for localized effects; minimal systemic absorption into the bloodstream. A study used 250 mg CBD oil applied for 4 weeks. Unlikely to cause systemic drug interactions but research is limited. Patients with peripheral neuropathy.
Inhalation (e.g., Vaping) Enters the bloodstream quickly through the lungs, bypassing the digestive system and liver metabolism. Half-life is around 31 hours. Long-term safety of vaping is a significant concern. Rapid onset may not be desirable for all uses. Healthy volunteers.

Population Trade-Offs

Individuals with Liver Conditions: Given that both methotrexate and CBD are processed by the liver, individuals with pre-existing liver conditions should exercise extreme caution. The potential for combined liver stress is a significant concern, making professional medical guidance essential.

Patients on Multiple Medications: The risk of drug interactions extends beyond methotrexate. Because CBD can inhibit CYP450 enzymes, it has the potential to affect the metabolism of many other common medications, such as blood thinners, antidepressants, and other immunosuppressants. A comprehensive review of all medications with a healthcare provider is critical.

Safety and Professional Guidance

cbd and methotrexate

The primary safety concern with combining CBD and methotrexate is the potential for increased methotrexate toxicity due to metabolic inhibition and the theoretical risk of additive liver injury.

Side Effects of Methotrexate Include:
* Nausea and vomiting
* Mouth sores
* Fatigue, or "methotrexate fog"
* Bone marrow suppression (leading to low blood cell counts)
* Liver enzyme elevations
* Increased sensitivity to sunlight
* In rare cases, serious lung or kidney problems

Reported Side Effects of CBD Include:
* Tiredness or drowsiness
* Diarrhea
* Changes in appetite and weight
* Dry mouth
* In some cases, elevated liver enzymes, particularly at high doses

Due to these risks, self-prescribing this combination is not advisable. Anyone taking methotrexate should not start using CBD without first consulting their healthcare provider. A doctor can assess the individual's health status, review all medications, and determine if co-administration is appropriate. If they do proceed, regular and vigilant monitoring of blood work-including liver function tests and methotrexate levels-is paramount to ensure safety and adjust dosages as needed.

FAQ: Clarifying Common Questions

1. Can I safely take CBD with methotrexate?
There is no definitive "yes" or "no" without professional medical advice. The primary risk is that CBD can inhibit liver enzymes, potentially increasing methotrexate levels in your blood to a toxic range. Always consult the healthcare professional who prescribes your methotrexate before using any CBD product.

2. Are there any studies on combining CBD and methotrexate in humans?
Direct clinical trials in humans are very limited. An observational study suggested CBD could increase methotrexate levels. Most other data comes from animal studies, which indicate a potential for both protective effects and adverse interactions, but these findings have not been confirmed in humans.

3. Does the form of CBD (e.g., oil vs. gummies) matter for the interaction?
Yes. Orally ingested CBD, like gummies, is extensively metabolized by the liver, where the interaction with methotrexate's metabolic pathway is most likely to occur. Sublingual forms may partially bypass this, and topical forms are unlikely to cause a systemic interaction, but the data is not comprehensive enough to assume safety with any form.

4. What are the warning signs of a negative interaction?
Signs could mirror methotrexate toxicity, including severe nausea, fatigue, unusual bruising or bleeding, fever, signs of infection, yellowing of the skin or eyes (jaundice), or difficulty breathing. If you experience any of these symptoms, seek medical attention immediately.

5. Could CBD help with methotrexate side effects?
While some animal studies suggest CBD might reduce methotrexate-induced inflammation and organ damage, this is not proven in humans. Given the risk of increasing methotrexate toxicity, attempting to self-treat side effects with CBD could be dangerous and is not recommended.


This content is for informational purposes only. Always consult a healthcare professional before starting any supplement.